Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Security class unavailable · CUSIP: 589492107

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-21-000180
Form type
SC 13G
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Feb 12, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub